nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—GGCX—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—DHPS—glaucoma	0.0965	0.39	CbGpPWpGaD
Phylloquinone—Vitamin E—SOD1—glaucoma	0.0448	1	CrCbGaD
Phylloquinone—Necrosis—Carbachol—glaucoma	0.0265	0.0375	CcSEcCtD
Phylloquinone—Inflammation—Latanoprost—glaucoma	0.0196	0.0277	CcSEcCtD
Phylloquinone—Cyanosis—Brimonidine—glaucoma	0.0184	0.026	CcSEcCtD
Phylloquinone—Phlebitis—Carbachol—glaucoma	0.0175	0.0248	CcSEcCtD
Phylloquinone—Injection site pain—Acetazolamide—glaucoma	0.0166	0.0235	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—DHPS—glaucoma	0.0158	0.0638	CbGpPWpGaD
Phylloquinone—Inflammation—Apraclonidine—glaucoma	0.0157	0.0221	CcSEcCtD
Phylloquinone—Erythema—Echothiophate—glaucoma	0.0153	0.0216	CcSEcCtD
Phylloquinone—Inflammation—Bimatoprost—glaucoma	0.0152	0.0215	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Pilocarpine—glaucoma	0.0129	0.0183	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—TGFB2—glaucoma	0.0128	0.0518	CbGpPWpGaD
Phylloquinone—Inflammation—Travoprost—glaucoma	0.0128	0.0181	CcSEcCtD
Phylloquinone—Sweating increased—Carbachol—glaucoma	0.0127	0.018	CcSEcCtD
Phylloquinone—Pain—Dipivefrin—glaucoma	0.0127	0.018	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—glaucoma	0.0118	0.0476	CbGpPWpGaD
Phylloquinone—Sweating—Carbachol—glaucoma	0.0112	0.0158	CcSEcCtD
Phylloquinone—Hypersensitivity—Dipivefrin—glaucoma	0.011	0.0155	CcSEcCtD
Phylloquinone—Swelling—Brimonidine—glaucoma	0.0107	0.0152	CcSEcCtD
Phylloquinone—Pain—Echothiophate—glaucoma	0.0107	0.015	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CCND2—glaucoma	0.0102	0.0414	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Acetazolamide—glaucoma	0.0102	0.0144	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—CTSA—glaucoma	0.00986	0.0398	CbGpPWpGaD
Phylloquinone—Flushing—Carbachol—glaucoma	0.0097	0.0137	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—glaucoma	0.00911	0.0368	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—glaucoma	0.00853	0.0345	CbGpPWpGaD
Phylloquinone—Inflammation—Betaxolol—glaucoma	0.00844	0.0119	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—glaucoma	0.00835	0.0337	CbGpPWpGaD
Phylloquinone—Erythema—Latanoprost—glaucoma	0.00831	0.0117	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—DHPS—glaucoma	0.00749	0.0303	CbGpPWpGaD
Phylloquinone—Dyspnoea—Metipranolol—glaucoma	0.00745	0.0105	CcSEcCtD
Phylloquinone—Hypotension—Carteolol—glaucoma	0.00723	0.0102	CcSEcCtD
Phylloquinone—Hyperhidrosis—Carbachol—glaucoma	0.00718	0.0101	CcSEcCtD
Phylloquinone—Anaphylactic shock—Methazolamide—glaucoma	0.00701	0.0099	CcSEcCtD
Phylloquinone—Hypotension—Carbachol—glaucoma	0.00694	0.00981	CcSEcCtD
Phylloquinone—Dyspnoea—Carteolol—glaucoma	0.0069	0.00975	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.00685	0.0277	CbGpPWpGaD
Phylloquinone—Hypotension—Levobunolol—glaucoma	0.00683	0.00966	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—NR3C1—glaucoma	0.00678	0.0274	CbGpPWpGaD
Phylloquinone—Sweating—Dorzolamide—glaucoma	0.00668	0.00944	CcSEcCtD
Phylloquinone—Erythema—Apraclonidine—glaucoma	0.00664	0.00939	CcSEcCtD
Phylloquinone—Dyspnoea—Levobunolol—glaucoma	0.00652	0.00921	CcSEcCtD
Phylloquinone—Erythema—Bimatoprost—glaucoma	0.00644	0.0091	CcSEcCtD
Phylloquinone—Pain—Carbachol—glaucoma	0.00635	0.00897	CcSEcCtD
Phylloquinone—Flushing—Acetazolamide—glaucoma	0.00634	0.00895	CcSEcCtD
Phylloquinone—Sweating—Pilocarpine—glaucoma	0.00631	0.00892	CcSEcCtD
Phylloquinone—Pain—Levobunolol—glaucoma	0.00625	0.00884	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.00623	0.0252	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Metipranolol—glaucoma	0.00616	0.0087	CcSEcCtD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.0061	0.0247	CbGpPWpGaD
Phylloquinone—Flushing—Brimonidine—glaucoma	0.00608	0.00859	CcSEcCtD
Phylloquinone—Dyspnoea—Latanoprost—glaucoma	0.00605	0.00854	CcSEcCtD
Phylloquinone—Immune system disorder—Brimonidine—glaucoma	0.00592	0.00836	CcSEcCtD
Phylloquinone—Pain—Latanoprost—glaucoma	0.0058	0.00819	CcSEcCtD
Phylloquinone—Erythema—Brimonidine—glaucoma	0.0057	0.00806	CcSEcCtD
Phylloquinone—Hypersensitivity—Carteolol—glaucoma	0.0057	0.00806	CcSEcCtD
Phylloquinone—Immune system disorder—Travoprost—glaucoma	0.00563	0.00795	CcSEcCtD
Phylloquinone—Immune system disorder—Brinzolamide—glaucoma	0.00556	0.00785	CcSEcCtD
Phylloquinone—Dizziness—Metipranolol—glaucoma	0.00552	0.00781	CcSEcCtD
Phylloquinone—Flushing—Pilocarpine—glaucoma	0.00549	0.00775	CcSEcCtD
Phylloquinone—Erythema—Dorzolamide—glaucoma	0.00545	0.0077	CcSEcCtD
Phylloquinone—Erythema—Travoprost—glaucoma	0.00542	0.00766	CcSEcCtD
Phylloquinone—Hypersensitivity—Levobunolol—glaucoma	0.00539	0.00761	CcSEcCtD
Phylloquinone—Erythema—Brinzolamide—glaucoma	0.00535	0.00757	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CDKN2A—glaucoma	0.00525	0.0212	CbGpPWpGaD
Phylloquinone—Dizziness—Carteolol—glaucoma	0.00512	0.00723	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—MMP9—glaucoma	0.00506	0.0204	CbGpPWpGaD
Phylloquinone—Sweating—Clonidine—glaucoma	0.00504	0.00712	CcSEcCtD
Phylloquinone—Dizziness—Diclofenamide—glaucoma	0.00503	0.00711	CcSEcCtD
Phylloquinone—Dizziness—Carbachol—glaucoma	0.00491	0.00694	CcSEcCtD
Phylloquinone—Anaphylactic shock—Acetazolamide—glaucoma	0.00485	0.00685	CcSEcCtD
Phylloquinone—Dizziness—Levobunolol—glaucoma	0.00484	0.00683	CcSEcCtD
Phylloquinone—Dyspnoea—Apraclonidine—glaucoma	0.00483	0.00683	CcSEcCtD
Phylloquinone—Dyspnoea—Bimatoprost—glaucoma	0.00469	0.00662	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—CTSA—glaucoma	0.00468	0.0189	CbGpPWpGaD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CDKN1B—glaucoma	0.00465	0.0188	CbGpPWpGaD
Phylloquinone—Pain—Apraclonidine—glaucoma	0.00464	0.00655	CcSEcCtD
Phylloquinone—Pain—Bimatoprost—glaucoma	0.0045	0.00635	CcSEcCtD
Phylloquinone—Dizziness—Latanoprost—glaucoma	0.00448	0.00634	CcSEcCtD
Phylloquinone—Anaphylactic shock—Dorzolamide—glaucoma	0.00445	0.00628	CcSEcCtD
Phylloquinone—Sweating—Betaxolol—glaucoma	0.00439	0.0062	CcSEcCtD
Phylloquinone—Hypotension—Brimonidine—glaucoma	0.00435	0.00615	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ACE2—glaucoma	0.0043	0.0174	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Dorzolamide—glaucoma	0.0043	0.00607	CcSEcCtD
Phylloquinone—Hypotension—Dorzolamide—glaucoma	0.00415	0.00587	CcSEcCtD
Phylloquinone—Dyspnoea—Brimonidine—glaucoma	0.00415	0.00586	CcSEcCtD
Phylloquinone—Hypotension—Travoprost—glaucoma	0.00414	0.00584	CcSEcCtD
Phylloquinone—Erythema—Clonidine—glaucoma	0.00411	0.00581	CcSEcCtD
Phylloquinone—Hypotension—Brinzolamide—glaucoma	0.00408	0.00577	CcSEcCtD
Phylloquinone—Hyperhidrosis—Pilocarpine—glaucoma	0.00406	0.00574	CcSEcCtD
Phylloquinone—Hypersensitivity—Apraclonidine—glaucoma	0.00399	0.00564	CcSEcCtD
Phylloquinone—Pain—Brimonidine—glaucoma	0.00398	0.00562	CcSEcCtD
Phylloquinone—Dyspnoea—Dorzolamide—glaucoma	0.00396	0.0056	CcSEcCtD
Phylloquinone—Dyspnoea—Travoprost—glaucoma	0.00395	0.00558	CcSEcCtD
Phylloquinone—Hypotension—Pilocarpine—glaucoma	0.00393	0.00555	CcSEcCtD
Phylloquinone—Dyspnoea—Brinzolamide—glaucoma	0.0039	0.0055	CcSEcCtD
Phylloquinone—Flushing—Betaxolol—glaucoma	0.00381	0.00539	CcSEcCtD
Phylloquinone—Pain—Dorzolamide—glaucoma	0.0038	0.00537	CcSEcCtD
Phylloquinone—Pain—Travoprost—glaucoma	0.00379	0.00535	CcSEcCtD
Phylloquinone—Dyspnoea—Pilocarpine—glaucoma	0.00374	0.00529	CcSEcCtD
Phylloquinone—Pain—Brinzolamide—glaucoma	0.00374	0.00528	CcSEcCtD
Phylloquinone—Immune system disorder—Betaxolol—glaucoma	0.00371	0.00525	CcSEcCtD
Phylloquinone—Pain—Pilocarpine—glaucoma	0.00359	0.00508	CcSEcCtD
Phylloquinone—Sweating—Timolol—glaucoma	0.00359	0.00507	CcSEcCtD
Phylloquinone—Dizziness—Apraclonidine—glaucoma	0.00359	0.00507	CcSEcCtD
Phylloquinone—Erythema—Betaxolol—glaucoma	0.00358	0.00506	CcSEcCtD
Phylloquinone—Dizziness—Bimatoprost—glaucoma	0.00348	0.00491	CcSEcCtD
Phylloquinone—Hypersensitivity—Brimonidine—glaucoma	0.00343	0.00485	CcSEcCtD
Phylloquinone—Hypersensitivity—Dorzolamide—glaucoma	0.00328	0.00463	CcSEcCtD
Phylloquinone—Hypersensitivity—Travoprost—glaucoma	0.00326	0.00461	CcSEcCtD
Phylloquinone—Hyperhidrosis—Clonidine—glaucoma	0.00324	0.00458	CcSEcCtD
Phylloquinone—Hypersensitivity—Brinzolamide—glaucoma	0.00322	0.00455	CcSEcCtD
Phylloquinone—Dizziness—Acetazolamide—glaucoma	0.00321	0.00453	CcSEcCtD
Phylloquinone—Hypotension—Clonidine—glaucoma	0.00313	0.00443	CcSEcCtD
Phylloquinone—Hypersensitivity—Pilocarpine—glaucoma	0.00309	0.00437	CcSEcCtD
Phylloquinone—Dizziness—Brimonidine—glaucoma	0.00308	0.00435	CcSEcCtD
Phylloquinone—Immune system disorder—Timolol—glaucoma	0.00303	0.00429	CcSEcCtD
Phylloquinone—Dyspnoea—Clonidine—glaucoma	0.00299	0.00423	CcSEcCtD
Phylloquinone—Dizziness—Dorzolamide—glaucoma	0.00294	0.00415	CcSEcCtD
Phylloquinone—Dizziness—Travoprost—glaucoma	0.00293	0.00414	CcSEcCtD
Phylloquinone—Erythema—Timolol—glaucoma	0.00292	0.00413	CcSEcCtD
Phylloquinone—Dizziness—Brinzolamide—glaucoma	0.00289	0.00408	CcSEcCtD
Phylloquinone—Pain—Clonidine—glaucoma	0.00287	0.00405	CcSEcCtD
Phylloquinone—Hyperhidrosis—Betaxolol—glaucoma	0.00282	0.00399	CcSEcCtD
Phylloquinone—Dizziness—Pilocarpine—glaucoma	0.00278	0.00392	CcSEcCtD
Phylloquinone—Hypotension—Betaxolol—glaucoma	0.00273	0.00386	CcSEcCtD
Phylloquinone—Dyspnoea—Betaxolol—glaucoma	0.0026	0.00368	CcSEcCtD
Phylloquinone—Pain—Betaxolol—glaucoma	0.0025	0.00353	CcSEcCtD
Phylloquinone—Hypersensitivity—Clonidine—glaucoma	0.00247	0.00349	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—TP53—glaucoma	0.00246	0.00993	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Timolol—glaucoma	0.00239	0.00337	CcSEcCtD
Phylloquinone—Hyperhidrosis—Timolol—glaucoma	0.00231	0.00326	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PAX6—glaucoma	0.0023	0.00928	CbGpPWpGaD
Phylloquinone—Hypotension—Timolol—glaucoma	0.00223	0.00315	CcSEcCtD
Phylloquinone—Dizziness—Clonidine—glaucoma	0.00222	0.00313	CcSEcCtD
Phylloquinone—Hypersensitivity—Betaxolol—glaucoma	0.00215	0.00304	CcSEcCtD
Phylloquinone—Dyspnoea—Timolol—glaucoma	0.00213	0.00301	CcSEcCtD
Phylloquinone—Pain—Timolol—glaucoma	0.00204	0.00288	CcSEcCtD
Phylloquinone—Dizziness—Betaxolol—glaucoma	0.00193	0.00273	CcSEcCtD
Phylloquinone—Hypersensitivity—Timolol—glaucoma	0.00176	0.00248	CcSEcCtD
Phylloquinone—Dizziness—Timolol—glaucoma	0.00158	0.00223	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—MMP1—glaucoma	0.00131	0.00528	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—MMP2—glaucoma	0.00101	0.00409	CbGpPWpGaD
